Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription 02.11.2026 2 Ann Neurol 1 Biochemistry (Mosc) 2 Exp Neurol 3 J Neural Transm (Vienna) 1 J Neurosci 6 Mov Disord 1 Nat Neurosci 1 Neurochem Res 1 Neurology 1 PLoS Comput Biol 2 PLoS One 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. VIZCARRA JA, Hefter K, Duong MT, Ertefaie A, et al
   Prediction of First and Recurrent Falls in Parkinson's Disease.
   Ann Neurol. 2026 Oct 30. doi: 10.1002/ana.78400.
   PubMed         Abstract available
   
   
2. DERAZ HA, Dwivedi AK, Duque KR, Bloemer A, et al
   Ambulatory Episodic Hypertension in Parkinson's Disease With Orthostatic Hypotension.
   Ann Neurol. 2026 Oct 24. doi: 10.1002/ana.78393.
   PubMed         Abstract available
   
   

   
   Biochemistry (Mosc)

3. ALPERINA EL, Idova GV, Zhanaeva SY, Tikhonova MA, et al
   Spatiotemporal Changes in the Cytokine Profile in the Brain of A53T Transgenic Mice, a Model of Parkinson's Disease.
   Biochemistry (Mosc). 2026;91:1991-2000.
   PubMed         Abstract available
   
   

   
   Exp Neurol

4. WU M, Liu T, Zong R, Yu L, et al
   The deubiquitinase OTUD1 aggravated dopaminergic neurodegeneration in Parkinson's disease model by promoting the degradation of Parkin.
   Exp Neurol. 2026;408:116080.
   PubMed         Abstract available
   
   
5. SHAO J, Deng Q, Yang L
   Photobiomodulation in Parkinson's disease: From pathogenesis to intervention.
   Exp Neurol. 2026;408:116088.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

6. SANTOS-LOBATO BL, de Souza Machado TP, Correa LVS, Gomes MZ, et al
   Neuroinflammation in levodopa-induced dyskinesia in Parkinson's disease: current state of the art.
   J Neural Transm (Vienna). 2026 Oct 27. doi: 10.1007/s00702-026-03317.
   PubMed         Abstract available
   
   
7. HOGLINGER G, Eggert K, Classen J, van Eimeren T, et al
   Improving the clinical trial landscape for Parkinson syndromes in Germany.
   J Neural Transm (Vienna). 2026 Oct 24. doi: 10.1007/s00702-026-03314.
   PubMed         Abstract available
   
   
8. WINKLER J
   Twenty-five years of progress in Parkinson's disease research: from dopamine replacement to biological definition and regenerative therapy.
   J Neural Transm (Vienna). 2026 Oct 24. doi: 10.1007/s00702-026-03308.
   PubMed         Abstract available
   
   

   
   J Neurosci

9. FRICKE C, Muehlberg C, Juettner P, Psurek F, et al
   Micro-online and Micro-offline Learning Reflect Stable Yet Randomly Distributed Strategies in Motor Skill Acquisition.
   J Neurosci. 2026;46:e0498262026.
   PubMed         Abstract available
   
   

   
   Mov Disord

10. QI S, Wu Y, Chao M, Xu L, et al
    Latent Class Trajectory Modeling Identifies Cerebrospinal Fluid Protein Signatures Associated with Motor Progression in Parkinson's Disease: Evidence from the Parkinson's Progression Markers Initiative Cohort.
    Mov Disord. 2026 Oct 23. doi: 10.1002/mds.70589.
    PubMed         Abstract available
    
    
11. SHAIK J, Zhang W, Zentsch V, Buhmann C, et al
    Remote Versus In-Person Follow-up Programming After Subthalamic Deep Brain Stimulation for Parkinson's Disease: A Multicenter Randomized Noninferiority Trial.
    Mov Disord. 2026 Oct 23. doi: 10.1002/mds.70575.
    PubMed         Abstract available
    
    
12. ZHANG S, Leng J, Wan G, Wang Q, et al
    Glymphatic Dysfunction Drives High-Urea-Induced Neurodegeneration in Parkinson's Disease.
    Mov Disord. 2026 Oct 26. doi: 10.1002/mds.70565.
    PubMed         Abstract available
    
    
13. AKANDE R, Kustermann T, Holiga S, Anzures-Cabrera J, et al
    Neuromelanin-Sensitive MRI as a Marker of Clinical Severity and Disease Burden in Parkinson's Disease: A Systematic Review and Meta-analysis.
    Mov Disord. 2026 Oct 28. doi: 10.1002/mds.70588.
    PubMed         Abstract available
    
    
14. KERN DS, Fasano A
    High-Intensity Focused Ultrasound of Bilateral Pallidothalamic Tracts for Parkinson's Disease: Are We Ready?
    Mov Disord. 2026 Oct 28. doi: 10.1002/mds.70577.
    PubMed        
    
    
15. AMMANN C, Pagge C, Wilhelm E, Galletti C, et al
    Motor Cortex Disinhibition Is Dissociated from Clinical Motor Features in Parkinson's Disease: Longitudinal Evidence.
    Mov Disord. 2026 Oct 30. doi: 10.1002/mds.70517.
    PubMed         Abstract available
    
    

    
    Nat Neurosci

16. LIU L, Hong Y, Wang X, Huang X, et al
    Microglial NUS1 deficiency drives dopaminergic neurodegeneration through intercellular iron dysregulation in Parkinson's disease models.
    Nat Neurosci. 2026 Oct 26. doi: 10.1038/s41593-026-02499.
    PubMed         Abstract available
    
    

    
    Neurochem Res

17. BASAEIDOOEI M, Edalatmanesh MA, Forouzanfar M
    Hydroxytyrosol Attenuates Reserpine-Induced Parkinsonism and Hippocampal Damage by Downregulating Pro-inflammatory MAPK/AP-1-Related Gene Expression.
    Neurochem Res. 2026;51:308.
    PubMed         Abstract available
    
    

    
    Neurology

18. DOLAN E, Donlon E, Fearon C
    Teaching Video NeuroImage: Osmotic Demyelination Syndrome With Appropriate Sodium Correction Causing Isolated Basal Ganglia Demyelination and Reversible Parkinsonism.
    Neurology. 2026;107:e218667.
    PubMed        
    
    

    
    PLoS Comput Biol

19. SHEHEITLI H, Johnson LA, Wang J, Aman JE, et al
    Coupled beta and high-frequency oscillations emerge from synchronized bursting in a minimal model of the parkinsonian subthalamic nucleus.
    PLoS Comput Biol. 2026;22:e1014921.
    PubMed         Abstract available
    
    

    
    PLoS One

20. LIAN SL, Storas TH, Gloersen EM, Lovland G, et al
    Understanding Glymphatic's Role In Proteinopathies (GRIP): A single centre case-control study protocol.
    PLoS One. 2026;21:e0360617.
    PubMed         Abstract available
    
    
21. CHEN J, Hu Q, Wei S, Zhang D, et al
    Clinical and genetic characteristics of patients with early-onset or familial parkinsonism: A retrospective single-center cohort.
    PLoS One. 2026;21:e0361198.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

22. PINTO WBVR, Sgobbi P, Alvarenga EC, Mesquita VA, et al
    Motor neuron disease and parkinsonism in a patient with a pathogenic CSF1R variant.
    Rev Neurol (Paris). 2026 Oct 26:S0035-3787(26)00614.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum